Maxim D. Hammer, MD Department of Neurology, The Cleveland Clinic
Derk W. Krieger, MD, PhD Section of Stroke and Neurologic Intensive Care, Department of Neurology, The Cleveland Clinic; Co-principal investigator, Cooling for Acute Ischemic Brain Damage (COOL AID) study
Address: Derk W. Krieger, MD, PhD, Department of Neurology, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kreiged@ccf.org
Dr. Krieger has indicated that he has received grant or research support from Radiant Medical Inc, is a consultant for Medcool, Inc, and is on the speakers’ bureaus of Sanofi-Synthelabo and the Bristol-Myers Squibb Company.
This paper discusses treatment that is not approved by the US Food and Drug Administration for the use under discussion.
ABSTRACTPreliminary clinical trials suggest that therapeutic hypothermia might improve the outcomes of patients with acute stroke. Definitive trials are under way.
